Display options
Cite
Yan P, Huang Z, Zhu J, et al. Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway. Oncol Lett. 2017;14(3):3148-3154doi: 10.3892/ol.2017.6564.
Yan, P., Huang, Z., Zhu, J., Bleahu, A., Dávila, J. D., & Friel, S. (2017). Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway. Oncology letters, 14(3), 3148-3154. https://doi.org/10.3892/ol.2017.6564
Yan, Penghui, et al. "Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway." Oncology letters vol. 14,3 (2017): 3148-3154. doi: https://doi.org/10.3892/ol.2017.6564
Yan P, Huang Z, Zhu J, Bleahu A, Dávila JD, Friel S. Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway. Oncol Lett. 2017 Sep;14(3):3148-3154. doi: 10.3892/ol.2017.6564. Epub 2017 Jul 08. PMID: 28927059; PMCID: PMC5588069.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Sep;14(3):3148-3154. doi: 10.3892/ol.2017.6564. Epub 2017 Jul 08.

Matrine inhibits cell proliferation and induces apoptosis of human rhabdomyosarcoma cells via downregulation of the extracellular signal-regulated kinase pathway.

Oncology letters

Penghui Yan, Zongqiang Huang, Junbo Zhu, Bleahu, Dávila, Friel

Affiliations

  1. Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China.

PMID: 28927059 PMCID: PMC5588069 DOI: 10.3892/ol.2017.6564

Abstract

Matrine, extracted from the Chinese traditional medicine

Keywords: ERK signaling; apoptosis; matrine; proliferation; rabdomyosarcoma

References

  1. Expert Rev Mol Diagn. 2017 Feb;17 (2):189-194 - PubMed
  2. Mol Cancer Ther. 2011 Jan;10(1):159-68 - PubMed
  3. Cancer Cell. 2015 Aug 10;28(2):170-82 - PubMed
  4. Biochem Biophys Res Commun. 2016 Aug 12;477(1):83-90 - PubMed
  5. Oncotarget. 2017 Feb 14;8(7):11621-11628 - PubMed
  6. Tumour Biol. 2014 Jun;35(6):5111-9 - PubMed
  7. Mol Cancer Ther. 2009 Mar;8(3):543-51 - PubMed
  8. Cancer Med. 2016 May;5(5):795-805 - PubMed
  9. Cancer Discov. 2014 Feb;4(2):216-31 - PubMed
  10. Oncol Rep. 2015 May;33(5):2561-6 - PubMed
  11. J Clin Oncol. 2016 Jan 10;34(2):105-6 - PubMed
  12. J Clin Oncol. 2016 Jan 10;34(2):117-22 - PubMed
  13. Oncol Rep. 2017 Jan;37(1):98-104 - PubMed
  14. J Cell Mol Med. 2017 Jun;21(6):1171-1181 - PubMed
  15. Oncol Rep. 2014 Sep;32(3):1087-93 - PubMed
  16. Cancer Lett. 2015 Nov 1;368(1):126-34 - PubMed
  17. Cancer Lett. 2013 Sep 1;337(2):200-9 - PubMed
  18. Sarcoma. 2012;2012:406239 - PubMed
  19. Cold Spring Harb Perspect Med. 2014 Nov 03;4(11):a025650 - PubMed
  20. Mol Cancer. 2016 Feb 20;15:16 - PubMed
  21. Oncol Lett. 2016 Sep;12(3):1854-1860 - PubMed
  22. Int J Oncol. 2015 Aug;47(2):517-26 - PubMed
  23. Int J Clin Exp Pathol. 2015 Nov 01;8(11):14793-9 - PubMed
  24. Panminerva Med. 2013 Sep;55(3):291-6 - PubMed
  25. Anticancer Drugs. 2014 Oct;25(9):1035-43 - PubMed

Publication Types